跳至主要内容
临床试验/NCT00396396
NCT00396396Unknown不适用

Role of Acetylcysteine in Creatinine Clearance

Eastern Virginia Medical School2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2006年10月最近更新:
适应症
相关药物

试验速览

阶段
不适用
入组人数
35
试验地点
2

研究概览

简要总结

The purpose of this study is to investigate the exact role of Acetylcysteine (Mucomyst) in altering creatinine clearance. Prior studies have shown the protective effects of Acetylcysteine on contrast-induced renal dysfunction. In these studies, Acetylcysteine lowered the incidence of serum creatinine elevation after administration of radiographic contrast agents. Not only was the increase in serum creatinine prevented, the studies also demonstrated a significant increase in creatinine clearance after administration of the agent. These prior studies did not evaluate if the increase in creatinine clearance was indeed from a protective benefit of Acetylcysteine in preserving the GFR versus simply increasing the proximal tubular creatinine secretion without actually affecting the GFR. We propose an experiment to help support our hypothesis that Acetylcysteine increases creatinine clearance via an increase in proximal tubular secretion of creatinine.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
盲法
None

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 18 and 79 years
  • In good general health
  • Able to provide informed consent

排除标准

  • Allergy to acetylcysteine or cimetidine,
  • Age less than 18 years or greater than 79 years of age,
  • Women of childbearing age and not able to use adequate contraception, or
  • Anyone currently on any medication that interferes with tubular secretion of creatinine such as trimethoprim-sulfamethoxazole (Bactrim).

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验